Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0796
    +0.0002 (+0.02%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2635
    +0.0013 (+0.10%)
     
  • USD/JPY

    151.2260
    -0.1460 (-0.10%)
     
  • Bitcoin USD

    69,179.62
    -2,105.83 (-2.95%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Today's Research Reports on Trending Tickers: Edwards Lifesciences and Globus Medical

NEW YORK, NY / ACCESSWIRE / December 7, 2018 / U.S. equities finished modestly lower on Thursday as trade concerns were reignited after the arrest of a Huawei senior executive. The Dow Jones Industrial Average fell 0.32 percent to close at 24,947.67, while the S&P 500 Index decreased 0.15 percent to close at 2,695.95. The Nasdaq Composite Index gained 0.42 percent to close at 7,188.26.

Head of Research at LCG, Jasper Lawler said, “The timing of the arrest is key here. Markets are already incredibly nervous over slowing economic growth thanks to the inverted U.S. yield curve. Relations between the U.S. and China were supposed to be on the mend after a productive G-20. However, the arrest has the potential to shatter very fragile U.S.-Sino relations which will weigh further on global trade and growth concerns.”

The Market Edge Initiates Coverage on:

Edwards Lifesciences Corporation
https://marketedgereport.com/report/EW/

Globus Medical, Inc.
https://marketedgereport.com/report/GMED/

Edwards Lifesciences’ stock jumped 3.8% Thursday, to close the day at $163.33. The stock recorded a trading volume of 2,446,582 shares, which was above its three months average volume of 1,756,434 shares. In the last year, Edwards Lifesciences’ shares have traded in a range of 110.68 - 175.00. The share price has gained 47.57% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $151.25 is above its 200-day moving average of $147.79. Shares of the company are trading at a Price to Earnings ratio of 49.15. Shares of Edwards Lifesciences have gained roughly 6.94 percent in the past month and are up 44.91 percent year-to-date.

Access The Market Edge's Edwards Lifesciences Corporation ResearchReport:
https://marketedgereport.com/report/EW/

On Thursday, shares of Globus Medical recorded a trading volume of 982,522 shares, which was above the three months average volume of 720,800 shares. The stock ended the day 3.08% higher at $47.47. The share price has fallen 17.91% from its 52 week high with a 52 week trading range of 38.01 - 57.83. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $52.02 is below its 200-day moving average of $52.81. Shares of the company are trading at a Price to Earnings ratio of 33.13. Shares of Globus Medical have fallen roughly 15.1 percent in the past month and are up 15.5 percent year-to-date.

Access The Market Edge's Globus Medical, Inc. Research Report:
https://marketedgereport.com/report/GMED/

Our Actionable Research on Edwards Lifesciences Corporation (NYSE:EW) and Globus Medical, Inc. (NYSE:GMED) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge

Advertisement